XAF1 as a modifier of p53 function and cancer susceptibility.
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
26
11
2019
accepted:
14
05
2020
entrez:
9
7
2020
pubmed:
9
7
2020
medline:
9
7
2020
Statut:
epublish
Résumé
Cancer risk is highly variable in carriers of the common
Identifiants
pubmed: 32637605
doi: 10.1126/sciadv.aba3231
pii: aba3231
pmc: PMC7314530
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
eaba3231Subventions
Organisme : NCI NIH HHS
ID : P30 CA021765
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA217657
Pays : United States
Informations de copyright
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Références
Hum Mutat. 2010 Feb;31(2):143-50
pubmed: 19877175
Oncogenesis. 2012 Feb 20;1:e1
pubmed: 23552518
Cold Spring Harb Perspect Med. 2016 Dec 1;6(12):
pubmed: 27663983
J Clin Oncol. 2018 Jul 10;36(20):2078-2087
pubmed: 29847298
Nat Rev Cancer. 2017 Apr;17(4):239-253
pubmed: 28256574
Proc Natl Acad Sci U S A. 2017 May 30;114(22):5683-5688
pubmed: 28507149
JAMA Oncol. 2017 Oct 1;3(10):1400-1402
pubmed: 28114597
Cell Growth Differ. 1990 Dec;1(12):571-80
pubmed: 2288874
PLoS One. 2011 Mar 22;6(3):e18015
pubmed: 21445348
Nat Cell Biol. 2001 Feb;3(2):128-33
pubmed: 11175744
Proc Natl Acad Sci U S A. 1987 Apr;84(8):2363-7
pubmed: 3470801
Biostatistics. 2003 Apr;4(2):249-64
pubmed: 12925520
J Clin Oncol. 2013 Jul 10;31(20):2619-26
pubmed: 23733769
Carcinogenesis. 2017 Oct 26;38(11):1112-1118
pubmed: 28968711
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
PLoS Genet. 2014 Apr 17;10(4):e1004234
pubmed: 24743097
Nat Rev Genet. 2001 Mar;2(3):165-74
pubmed: 11256068
Clinics (Sao Paulo). 2007 Apr;62(2):167-74
pubmed: 17505702
Nat Rev Clin Oncol. 2014 May;11(5):260-71
pubmed: 24642672
Nat Genet. 2002 Jan;30(1):97-101
pubmed: 11731797
Cell Death Dis. 2018 Jul 24;9(8):806
pubmed: 30042418
Arq Bras Endocrinol Metabol. 2004 Oct;48(5):647-50
pubmed: 15761534
Sci Rep. 2015 Oct 07;5:14838
pubmed: 26443201
Bioinformatics. 2019 Jul 15;35(14):2495-2497
pubmed: 30520965
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15532-7
pubmed: 25313037
Science. 2019 Mar 15;363(6432):1150-1151
pubmed: 30872507
Sci Rep. 2019 Mar 12;9(1):4194
pubmed: 30862905
Mol Cancer Res. 2017 Aug;15(8):1051-1062
pubmed: 28483946
Cell. 1993 Nov 19;75(4):817-25
pubmed: 8242752
Nat Commun. 2015 Mar 06;6:6302
pubmed: 25743702
Cancer Lett. 2007 Jan 8;245(1-2):96-102
pubmed: 16494995
Nat Methods. 2013 Jan;10(1):5-6
pubmed: 23269371
Genes Dev. 1992 Jul;6(7):1143-52
pubmed: 1628822
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9330-5
pubmed: 11481490
J Clin Endocrinol Metab. 2001 Oct;86(10):4970-3
pubmed: 11600572
Hum Mutat. 2017 Jul;38(7):751-763
pubmed: 28332257
Genomics. 2000 Nov 15;70(1):113-22
pubmed: 11087668
Hypertension. 2018 Feb;71(2):273-279
pubmed: 29229744
J Med Genet. 2009 Nov;46(11):766-72
pubmed: 19542078
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Hered Cancer Clin Pract. 2014 Mar 13;12(1):8
pubmed: 24625245
Curr Opin Investig Drugs. 2007 Jun;8(6):469-76
pubmed: 17621877